Top compounds associated with response to KMT2D


Feature Type Standardized
Nominal ANOVA
mRNA etoposide CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-07
mRNA decitabine CTRPv2 pan-cancer AAC 0.16 2e-07
mRNA prima-1 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.24 3e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA alisertib CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA CD-437 CTRPv2 pan-cancer AAC 0.18 4e-07
Download CSV